{"id":"https://openalex.org/W7225834534","doi":"https://doi.org/10.3389/fphar.2026.1971846","title":"Intranasal deferiprone delivery increases brain exposure and ameliorates abnormal open-field behavior in a mouse model of brain iron dysregulation","display_name":"Intranasal deferiprone delivery increases brain exposure and ameliorates abnormal open-field behavior in a mouse model of brain iron dysregulation","publication_year":2026,"publication_date":"2026-11-11","ids":{"openalex":"https://openalex.org/W7225834534","doi":"https://doi.org/10.3389/fphar.2026.1971846"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1971846","doi":"https://doi.org/10.3389/fphar.2026.1971846","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1971846","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1971846/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1971846/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086970585","display_name":"Ruiying Cheng","orcid":"https://orcid.org/0009-0008-5194-7145","observed_orcids":["https://orcid.org/0009-0008-5194-7145","https://orcid.org/0000-0002-2949-8979"]},"institutions":[{"id":"https://openalex.org/I133738476","display_name":"University of Massachusetts Lowell","ror":"https://ror.org/03hamhx47","country_code":"US","type":"education","lineage":["https://openalex.org/I133738476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruiying Cheng","raw_affiliation_strings":["Department of Biomedical and Nutritional Sciences, University of Massachusetts Lowell"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical and Nutritional Sciences, University of Massachusetts Lowell","institution_ids":["https://openalex.org/I133738476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004243541","display_name":"Hwayoung Baek","orcid":"https://orcid.org/0009-0002-8536-6003","observed_orcids":["https://orcid.org/0009-0002-8536-6003"]},"institutions":[{"id":"https://openalex.org/I133738476","display_name":"University of Massachusetts Lowell","ror":"https://ror.org/03hamhx47","country_code":"US","type":"education","lineage":["https://openalex.org/I133738476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hwayoung Baek","raw_affiliation_strings":["Department of Biomedical and Nutritional Sciences, University of Massachusetts Lowell"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical and Nutritional Sciences, University of Massachusetts Lowell","institution_ids":["https://openalex.org/I133738476"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5161274331","display_name":"Jonghan Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133738476","display_name":"University of Massachusetts Lowell","ror":"https://ror.org/03hamhx47","country_code":"US","type":"education","lineage":["https://openalex.org/I133738476"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jonghan Kim","raw_affiliation_strings":["Department of Biomedical and Nutritional Sciences, University of Massachusetts Lowell"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical and Nutritional Sciences, University of Massachusetts Lowell","institution_ids":["https://openalex.org/I133738476"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5161274331"],"corresponding_institution_ids":["https://openalex.org/I133738476"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.4059999883174896,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.4059999883174896,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.30469998717308044,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13481","display_name":"Neurological diseases and metabolism","score":0.05909999832510948,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C85663871","wikidata":"https://www.wikidata.org/wiki/Q6966562","display_name":"Nasal administration","level":2,"score":0.8119999766349792},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.76910001039505},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.708299994468689},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6991999745368958},{"id":"https://openalex.org/C2776517179","wikidata":"https://www.wikidata.org/wiki/Q749664","display_name":"Deferiprone","level":3,"score":0.6923999786376953},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6269000172615051},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.5835999846458435},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5454999804496765},{"id":"https://openalex.org/C110121322","wikidata":"https://www.wikidata.org/wiki/Q865811","display_name":"Distribution (mathematics)","level":2,"score":0.43619999289512634},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.426800012588501},{"id":"https://openalex.org/C25938499","wikidata":"https://www.wikidata.org/wiki/Q7663812","display_name":"Systemic administration","level":3,"score":0.4101000130176544},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.3698999881744385},{"id":"https://openalex.org/C2780496858","wikidata":"https://www.wikidata.org/wiki/Q644945","display_name":"Olfactory bulb","level":3,"score":0.3109000027179718},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.2976999878883362},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.2904999852180481},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.2572000026702881}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fphar.2026.1971846","doi":"https://doi.org/10.3389/fphar.2026.1971846","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1971846","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1971846/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1971846","doi":"https://doi.org/10.3389/fphar.2026.1971846","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1971846","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1971846/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225834534.pdf","grobid_xml":"https://content.openalex.org/works/W7225834534.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W1795123","https://openalex.org/W1612293997","https://openalex.org/W1807086797","https://openalex.org/W1963945544","https://openalex.org/W1964271667","https://openalex.org/W1970068788","https://openalex.org/W1996931980","https://openalex.org/W2001525797","https://openalex.org/W2010594315","https://openalex.org/W2014985385","https://openalex.org/W2022708198","https://openalex.org/W2048352327","https://openalex.org/W2050030843","https://openalex.org/W2062516622","https://openalex.org/W2062851065","https://openalex.org/W2102178526","https://openalex.org/W2107405263","https://openalex.org/W2125289626","https://openalex.org/W2134978811","https://openalex.org/W2299808451","https://openalex.org/W2804592477","https://openalex.org/W2888724179","https://openalex.org/W2894231856","https://openalex.org/W2894773478","https://openalex.org/W2973121903","https://openalex.org/W2977337099","https://openalex.org/W3009000896","https://openalex.org/W3160104245","https://openalex.org/W3213843762","https://openalex.org/W4213336678","https://openalex.org/W4224212919","https://openalex.org/W4281651592","https://openalex.org/W4283735887","https://openalex.org/W4286111302","https://openalex.org/W4295757113","https://openalex.org/W4311024711","https://openalex.org/W4390235351","https://openalex.org/W4399054875","https://openalex.org/W4401231985","https://openalex.org/W4403305105","https://openalex.org/W4403916308","https://openalex.org/W4404024063","https://openalex.org/W4404929055","https://openalex.org/W4405572857","https://openalex.org/W4407085809","https://openalex.org/W4410008956","https://openalex.org/W4417449079"],"related_works":[],"abstract_inverted_index":{"Introduction":[0],"Although":[1],"brain":[2,53,78,220],"iron":[3,26,31,79,221],"dysregulation":[4],"has":[5,33,45],"been":[6,34,46],"implicated":[7],"in":[8,73,184],"neurological":[9],"and":[10,51,83,106,115,129,137,170,188,214],"neuropsychiatric":[11],"disorders,":[12,41],"its":[13,43],"potential":[14],"as":[15,65],"a":[16,74],"therapeutic":[17],"target":[18],"remains":[19],"unclear.":[20],"Deferiprone":[21],"(DFP),":[22],"an":[23,66],"oral":[24,95,138,145,163,198],"lipophilic":[25],"chelator":[27],"approved":[28],"for":[29,36,98],"systemic":[30,49],"overload,":[32],"explored":[35],"central":[37],"nervous":[38],"system":[39],"(CNS)":[40],"but":[42],"use":[44],"limited":[47],"by":[48,102],"toxicity":[50],"suboptimal":[52],"distribution.":[54],"In":[55,141],"this":[56],"study,":[57],"we":[58,126],"evaluated":[59,127],"intranasal":[60,206],"(IN)":[61],"delivery":[62,207],"of":[63,77,118,133,149],"DFP":[64,96,134,150,164,213],"alternative":[67],"strategy":[68],"to":[69,143,197,212],"modulate":[70],"impaired":[71],"neurobehavior":[72],"mouse":[75],"model":[76],"accumulation.":[80],"Methods":[81],"Wild\u2010type":[82],"H67D":[84],"mice":[85],"(male,":[86],"n":[87],"=":[88],"6\u201310":[89],"per":[90],"group)":[91],"received":[92],"IN":[93,119,136,147,194],"or":[94],"daily":[97],"7":[99],"days,":[100],"followed":[101],"open":[103],"field":[104],"testing":[105],"hematological":[107,116,159],"assessment.":[108],"To":[109],"determine":[110],"whether":[111],"the":[112,185],"behavioral":[113,152,176],"effects":[114,153],"tolerability":[117],"administration":[120,148,195],"were":[121],"associated":[122,218],"with":[123,219],"route\u2010dependent":[124],"exposure,":[125],"pharmacokinetics":[128],"compared":[130],"tissue":[131],"distribution":[132,183,191],"following":[135],"administration.":[139],"Results":[140],"contrast":[142],"high-dose":[144,162],"treatment,":[146],"produced":[151],"at":[154],"20":[155],"mg/kg":[156],"without":[157,173],"detectable":[158],"changes,":[160],"whereas":[161],"(100":[165],"mg/kg)":[166],"reduced":[167],"circulating":[168],"leukocyte":[169],"neutrophil":[171],"counts":[172],"producing":[174],"comparable":[175],"effects.":[177],"Pharmacokinetic":[178],"analysis":[179],"revealed":[180],"increased":[181],"drug":[182],"olfactory":[186],"bulb":[187],"distinct":[189],"brain-to-plasma":[190],"patterns":[192],"after":[193],"relative":[196],"dosing.":[199],"Conclusion":[200],"Collectively,":[201],"our":[202],"findings":[203],"demonstrate":[204],"that":[205],"alters":[208],"regional":[209],"CNS":[210],"exposure":[211],"improves":[215],"open-field":[216],"behavior":[217],"dysregulation.":[222]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-12T00:00:00"}